MetLife Investment Management’s SkinHealth Systems SKIN Stock Holding History

MetLife Investment Management’s Portfolio SKIN Stock Details SKIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,169	Closed	-$32.2K	–	2831
2025 Q4	$32.2K	Sell	23,169 -34,684	-60%	-$50.1K	﹤0.01%	2755
2025 Q3	$115K	Sell	57,853 -15,590	-21%	-$31.6K	﹤0.01%	2590
2025 Q2	$140K	Buy	+73,443	New	+$103K	﹤0.01%	2371
2024 Q3	–	Sell	-46,183	Closed	-$88.7K	–	2888
2024 Q2	$88.7K	Buy	46,183 +1,843	+4%	+$5.19K	﹤0.01%	2658
2024 Q1	$197K	Sell	44,340 -2,498	-5%	-$8.12K	﹤0.01%	2217
2023 Q4	$146K	Hold	46,838	–	–	﹤0.01%	2409
2023 Q3	$282K	Hold	46,838	–	–	﹤0.01%	1993
2023 Q2	$392K	Hold	46,838	–	–	﹤0.01%	1859
2023 Q1	$592K	Sell	46,838 -6,800	-13%	-$78.6K	﹤0.01%	1540
2022 Q4	$488K	Hold	53,638	–	–	﹤0.01%	1661
2022 Q3	$632K	Buy	53,638 +1,596	+3%	+$20.2K	0.01%	1464
2022 Q2	$669K	Buy	52,042 +3,262	+7%	+$43.7K	0.01%	1463
2022 Q1	$823K	Buy	48,780 +17,710	+57%	+$292K	0.01%	1453
2021 Q4	$751K	Hold	31,070	–	–	0.01%	1267
2021 Q3	$807K	Buy	31,070 +12,211	+65%	+$269K	0.01%	1240
2021 Q2	$317K	Buy	+18,859	New	+$258K	﹤0.01%	1851

Other funds holding SKIN

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

MetLife Investment Management's SKIN Position: Q1 2026 in Review

MetLife Investment Management sold out of SkinHealth Systems (SKIN) in Q1 2026, closing a stake of 23,169 shares — an estimated $32.2K sold.

MetLife Investment Management first reported a position in SKIN in Q2 2021 and held it in 16 quarters. The position peaked at $823K in Q1 2022. 116 funds tracked by Wall St. Rank hold SKIN as of Q1 2026.

MetLife Investment Management reported no remaining SkinHealth Systems position as of Q1 2026 after selling out during the quarter.
MetLife Investment Management sold 23,169 SkinHealth Systems shares in Q1 2026, an estimated $32.2K.
MetLife Investment Management first reported a position in SkinHealth Systems in Q2 2021 and held it in 16 quarters.
MetLife Investment Management's SkinHealth Systems position peaked at $823K in Q1 2022.
116 funds tracked by Wall St. Rank held SkinHealth Systems as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.